Protein and Peptide Delivery through Respiratory Pathway - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 469

Fujita T , Muranishi S . Absorption
of water-soluble compounds with different molecular weights and (Asu1,7)- eel calcito-
nin sfrom various mucosal administration sites . J Control Release 2001 ; 76 : 363 - 74 .
[81] Fisher N , Brown K , Davis SS , Parr GD , Smith DA . The effect of molecular size on
the nasal absorption of water-soluble compounds in the albino rat . J Pharm Pharmacol
1987 ; 39 : 357 - 62 .
[82] Maitani Y , Machida Y , Nagai T . Influence of molecular weight and charge on nasal
absorption of dextran and DEAE-dextran in rabbits . Int J Pharm 1989 ; 49 : 23 - 7 .
[83] Bates DV , Fish BR , Hatch TF , Mercer TT , Morrow PE . Deposition and retention mod-
els for internal dosimetry of the human respiratory tract. Task group on lung dynamics .
Health Phys 1966 ; 12 : 173 - 207 .
[84] Proctor DF , Andersen I , Lundqvist G . Clearance of inhaled particles from the human
nose . Arch Intern Med 1973 ; 131 : 132 - 9 .
[85] Lipworth BJ , Jackson CM . Safety of inhaled and intranasal corticosteroids: lessons for
the new millennium . Drug Saf 2000 ; 23 : 11 - 33 .
[86] Corbo DC , Liu JC , Chien YW . Drug absorption through mucosal membranes: effect of
mucosal route and penetrant hydrophilicity . Pharm Res 1989 ; 6 : 848 - 52 .
[87] Shao Z , Park G , Krishnamoorthy R , Mitra A . The physicochemical properties, plasma
enzymatic hydrolysis and nasal absorption of acyclovir and its 2- ester prodrugs . Pharm
Res 1994 ; 11 : 237 - 42 .
[88] Doelker E . Crystalline modifications and polymorphism changes during drug manufac-
ture . Ann Pharm Fr 2002 ; 60 : 161 - 76 .
[89] Morissette SL , Almarsson O , Peterson ML , Remenar JF , Read MJ , Lemm o A V , e t a l .
High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharma-
ceutical solids . Adv Drug Deliv Rev 2004 ; 56 : 275 - 300 .
[90] Raw AS , Furness MS , Gill DS , Adams RC , Holcombe FO Jr. , Yu LX . Regulatory consid-
erations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications
(ANDAs) . Adv Drug Deliv Rev 2004 ; 56 : 397 - 414 .
[91] Huang CH , Kimura R , Nassar R , Hussain AA . Mechanism of nasal absorption of drugs
II: absorption of L -tyrosine and the effect of structural modifications on its absorption .
J Pharm Sci 1985 ; 74 : 1298 - 301 .
[92] Shao Z , Mitra AK . Bile salt -fatty acid mixed micelles as nasal absorption promoters III.
Effects on nasal transport and enzymatic degradation of acyclovir prodrugs . Pharm Res
1994 ; 11 : 243 - 50 .
[93] Shao Z , Hoffman A , Mitra A . Biodegradation characteristics of acyclovir 2-ester pro-
drugs by respiratory carboxylesterases: implications in prodrug design for intranasal and
pulmonary drug delivery . Int J Pharm 1994 ; 112 : 181 - 90 .
[94] Pennington AK , Ratcliffe JH , Wilson CG , Hardy JG . The influence of viscosity on nasal
spray deposition and clearance . Int J Pharm 1988 ; 43 : 221 - 4 .
[95] Harris A , Ohlin M , Svensson E , Lethagen S , Nilsson I . Effect of viscosity on phar-
macokinetics and biological response to intranasal desmopressin . J Pharm Sci 1989 ;
78 : 470 - 1 .
[96] Suzuki Y , Makino Y . Mucosal drug delivery using cellulose derivatives as a functional
polymer . J Control Release 1999 ; 62 : 101 - 7 .
[97] Hussain AA , Bawarshi - Nassar R , Huang CH . Physicochemical consideration in intra-
nasal drug administration . In: Chien YW , editor. Transnasal systemic medications . N e w
York : Elsevier Science ; 1985 . p. 121 - 37 .
[98] Thamsborg G , Storm T , Sykulski R , Brinch E , Nielsen H , Sorensen O . Effect of different
doses of nasal salmon calcitonin on bone mass . Calcif Tissue Int 1991 ; 48 : 302 - 7 .

[80] Yamamoto A , Iseki T , Ochi - Sugiyama M , Okada N ,